Ken Yoshii
Koji Hosomi
Kento Sawane
Jun Kunisawa- 1Laboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research, and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan
- 2Graduate School of Medicine, Osaka University, Osaka, Japan
- 3Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
- 4Innovation Center, Nippon Flour Mills Co., Ltd., Atsugi, Japan
- 5Graduate School of Dentistry, Osaka University, Osaka, Japan
- 6Department of Microbiology and Immunology, Graduate School of Medicine, Kobe University, Hyogo, Japan
- 7Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Vitamins are micronutrients that have physiological effects on various biological responses, including host immunity. Therefore, vitamin deficiency leads to increased risk of developing infectious, allergic, and inflammatory diseases. Since B vitamins are synthesized by plants, yeasts, and bacteria, but not by mammals, mammals must acquire B vitamins from dietary or microbial sources, such as the intestinal microbiota. Similarly, some intestinal bacteria are unable to synthesize B vitamins and must acquire them from the host diet or from other intestinal bacteria for their growth and survival. This suggests that the composition and function of the intestinal microbiota may affect host B vitamin usage and, by extension, host immunity. Here, we review the immunological functions of B vitamins and their metabolism by intestinal bacteria with respect to the control of host immunity.
Introduction
The gut is continuously exposed both to toxic (e.g., pathogenic microorganisms) and beneficial (e.g., dietary components, commensal bacteria) compounds and microorganisms; therefore, the intestinal immune system must maintain a healthy balance between active and suppressive immune responses. This balance is controlled not only by host immune factors such as cytokines but also by a variety of environmental factors such as dietary components and the composition of the commensal bacteria. Furthermore, several lines of evidence have demonstrated that immune homeostasis in the intestine is related not only to intestinal health but also to the health of the whole body (1–3). Therefore, immune regulation by environmental factors is attracting attention as a means of maintaining immunological health and preventing many diseases.
Nutrients are essential for the development, maintenance, and function of the host immune system (4, 5). Vitamins are essential micronutrients that are synthesized by bacteria, yeasts, and plants, but not by mammals. Therefore, mammals must obtain vitamins from the diet or rely on their synthesis by commensal bacteria in the gastrointestinal tract. Some vitamins are water-soluble (e.g., vitamin B family and vitamin C), whereas others are fat-soluble (e.g., vitamins A, D, E, and K). Water-soluble vitamins are not stored by the body and any excess is excreted in the urine; therefore, it is important to consume a diet containing the necessary amounts of these vitamins. Vitamin deficiency associated with insufficient dietary intake occurs not only in developing countries but also in developed countries as a result of increased use of unbalanced diet (6).
In addition to the diet, the commensal bacteria are recognized as important players in the control of host health (7–9). From the point of view of vitamins, commensal bacteria are both providers and consumers of B vitamins and vitamin K. Although dietary B vitamins are generally absorbed through the small intestine, bacterial B vitamins are produced and absorbed mainly through the colon (10, 11), indicating that dietary and gut microbiota-derived B vitamins are possibly handled differently by the human body. B vitamins are important cofactors and coenzymes in several metabolic pathways, and it has been reported recently that B vitamins also play important roles in the maintenance of immune homeostasis (12, 13). Thus, both dietary components and the gut microbiota modulate host immune function via B vitamins. Here, we review the metabolism and function of dietary and gut microbiota-derived B vitamins in the control of host immunity.
Vitamin B1
Vitamin B1 (thiamine) is a cofactor for several enzymes, including pyruvate dehydrogenase and α-ketoglutarate dehydrogenase, which are both involved in the tricarboxylic acid (TCA) cycle (14, 15). World Health Organization (WHO)/Food and Agriculture Organization (FAO) recommend a daily vitamin B1 intake of 1.1–1.2 mg for adult (16). Vitamin B1 deficiency causes lethargy and, if left untreated, can develop into beriberi, a disease that affects the peripheral nervous system and cardiovascular system. Accumulating evidence suggests that energy metabolism—particularly the balance between glycolysis and the TCA cycle—is associated with the functional control of immune cells, in what is now referred to as immunometabolism (17).
Immunometabolism is well studied in T cells and macrophages; quiescent or regulatory-type cells (e.g., naive T cells, Treg cells, and M2 macrophages) use the TCA cycle for energy generation, whereas activated or pro-inflammatory cells (e.g., Th1, Th2, Th17, and M1 macrophages) use glycolysis (18, 19).
Previously, we examined B cell immunometabolism in the intestine. In the intestine, naïve immunoglobulin (Ig) M+ B cells differentiate into IgA+ B cells in Peyer's patches (PPs) by class switching, and then IgA+ B cells differentiate into IgA-producing plasma cells in the intestinal lamina propria (20). Naïve B cells in PPs preferentially use a vitamin B1-dependent TCA cycle for the generation of ATP. However, once the B cells differentiate into IgA-producing plasma cells, they switch to using glycolysis for the generation of ATP and shift to a catabolic pathway for the production of IgA antibody (Figure 1). Consistent with the importance of vitamin B1 in the maintenance of the TCA cycle, mice fed a vitamin B1-deficient diet show impaired maintenance of naïve B cells in PPs, with little effect on IgA-producing plasma cells. Since PPs are the primary sites of induction of antigen-specific IgA responses, PP regression induced by vitamin B1 deficiency leads to decreased IgA antibody responses to oral vaccines (21).
Figure 1. Vitamin B1 and B2-mediated immunometabolism in B cell differentiation in the intestine. Vitamin B1 acts as a cofactor for enzymes such as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase that are involved in the TCA cycle. Vitamin B2 acts as a cofactor for enzymes such as succinate dehydrogenase in the TCA cycle and acyl-CoA dehydrogenase in fatty acid oxidation (FAO, also known as β-oxidation). Naïve B cells preferentially use the TCA cycle for efficient energy generation. Once B cells are activated to differentiate into IgA-producing plasma cells, they utilize glycolysis for the production of IgA antibody.
Vitamin B1 is found in high concentrations as thiamine pyrophosphate (TPP) in meat (particularly pork and chicken); eggs; cereal sprouts and rice bran; and beans. Dietary TPP is hydrolyzed by alkaline phosphatase and converted to free thiamine in the small intestine (22). Free thiamine is absorbed by the intestinal epithelium via thiamine transporters (e.g., THTR-1, THTR-2) and transported to the blood for distribution throughout the body (11). Free thiamine is converted back to TPP and is used for energy metabolism in the TCA cycle.
Various types of intestinal bacteria, mostly in the colon, also produce vitamin B1 as both free thiamine and TPP (11, 23). In the colon, free bacterial thiamine is absorbed mainly by thiamine transporters, transported to the blood, and distributed throughout the body; this mechanism is similar to how free dietary thiamine is taken up in the small intestine. However, unlike in the small intestine, TPP produced by the gut microbiota is not converted to free thiamine, because alkaline phosphatase is not secreted in the colon (24). Instead, TPP is absorbed directly by the colon via TPP transporters (e.g., TPPT-1) that are highly expressed on the apical membrane of the colon (25). The absorbed TPP enters the mitochondria via MTPP-1, a TPP transporter that is expressed in the mitochondrial inner membrane and is used as a cofactor for ATP generation (26). This suggests that bacterial TPP is important for energy generation in the colon. Thus, dietary and bacterial vitamin B1 appears to have different roles in the host.
The vitamin B1 structure consists of a thiazole moiety linked to a pyrimidine moiety. Bacteria obtain the thiazole moiety from glycine or tyrosine and 1-deoxy-d-xylulose-5-phosphate, and plants and yeasts synthesize it from glycine and 2-pentulose (27–30). In both bacteria and plants, the pyrimidine moiety is derived from 5-aminoimidazole ribonucleotide, an intermediate in the purine pathway (29). Metagenomic analyses of the human gut microbiota predict that Bacteroides fragilis and Prevotella copri (phylum Bacteroidetes); Clostridium difficile, some Lactobacillus spp., and Ruminococcus lactaris (Firmicutes); Bifidobacterium spp. (Actinobacteria); and Fusobacterium varium are vitamin B1 producers (Table 1) (10, 46), implying that many intestinal bacteria possess a complete vitamin B1 synthesis pathway, which includes pathways for the synthesis of thiazole and pyrimidine. Indeed, Lactobacillus casei produces thiamine during the production of fermented milk drinks (31), and Bifidobacterium infantis and B. bifidum produce thiamine in culture supernatant (32). However, Faecalibacterium spp. (Firmicutes) lack a vitamin B1 synthesis pathway even though they require vitamin B1 for their growth (10). Therefore, these bacteria must obtain their vitamin B1 from other bacteria or from the host diet via a thiamine transporter, suggesting that there is competition for vitamin B1 between the host and certain intestinal bacteria.
Table 1. Vitamin B family producing bacteria.
Vitamin B2
Vitamin B2 (riboflavin) and its active forms (flavin adenine dinucleotide [FAD] and flavin mononucleotide [FMN]) are cofactors for enzymatic reactions in the TCA cycle and in fatty acid oxidization (also known as β-oxidization) (15). WHO/FAO recommends a daily vitamin B2 intake of 1.0–1.3 mg for adults (16). Vitamin B2 deficiency suppresses the activity of acyl-CoA dehydrogenases involved in the oxidation of fatty acids to generate acetyl-CoA, which is used by mitochondria to produce ATP via the TCA cycle. Fatty acid oxidization is involved in the activation, differentiation, and proliferation of immune cells through the generation of acetyl-CoA and its entry into TCA cycle (47). This suggests that vitamin B2 is associated with the control of differentiation and function of immune cells through regulation of fatty acid oxidization (Figure 1); however, the immunological roles of vitamin B2 in the control of host immunity remain to be investigated. In addition to energy generation, vitamin B2 is associated with reactive oxygen species (ROS) generation in immune cells through the priming of NADPH oxidase 2 (48); ROS are important effector and signaling molecules in inflammation and immunity.
Vitamin B2 is found at high levels in leafy green vegetables, liver, and eggs. Dietary vitamin B2 exists as FAD or FMN and is converted to free riboflavin by FAD pyrophosphatase and FMN phosphatase in the small intestine (49, 50). Free riboflavin is absorbed via riboflavin transporter expressed on the epithelium of the small intestine and is then released into the blood. In the blood, free riboflavin is converted back to FAD or FMN and distributed throughout the body (51–53).
Bacterial vitamin B2 is synthesized from guanosine triphosphate (GTP) and d-ribulose 5-phosphate (54). Bacterial vitamin B2 exists as free riboflavin, which is directly absorbed in the large intestine, converted to FAD or FMN, and distributed throughout the body as described above (23). A metagenome analysis of the human gut microbiota by Magnúsdóttir et al. (10) has predicted that Bacteroides fragilis and Prevotella copri (Bacteroidetes); Clostridium difficile, Lactobacillus plantarum, L. fermentum, and Ruminococcus lactaris (Firmicutes) express factors essential for vitamin B2 synthesis, suggesting that these bacteria are an important source of vitamin B2 in the large intestine (Table 1). In contrast, Bifidobacterium spp., and Collinsella spp. (Actinobacteria) lack a vitamin B2 pathway. Supplementation of fermented soymilk containing Lactobacillus plantarum with riboflavin deficient diet has been shown to promote vitamin B2 production and prevent vitamin B2 deficiency in mice (35). L. fermentum isolated from sourdough can synthesize riboflavin in vitro (36). Furthermore, recent evidence indicates that some species in Bacteroidetes phylum produce more riboflavin than do Actinobacteria and Firmicutes phyla (55). However, Actinobacteria and Firmicutes phyla still express riboflavin transporter and the enzymes necessary for FAD and FMN generation from free riboflavin (i.e., FAD synthases and flavin kinases) (10, 56), suggesting that all bacteria, including those that are unable to synthesize vitamin B2 themselves, require FAD and FMN for their growth and survival. Thus, as with vitamin B1, there is likely competition for riboflavin between the host and the commensal bacteria.
In addition to being able to produce vitamin B2, some bacteria (e.g., commensals such as Lactobacillus acidophilus and pathogens such as Mycobacterium tuberculosis and Salmonella typhimurium) produce the vitamin B2 intermediate (57–59), 6-hydroxymethyl-8-d-ribityllumazine (60, 61). 6-Hydroxymethyl-8-d-ribityllumazine binds to major histocompatibility complex class I-related gene protein (MR1) on antigen-presenting cells; this causes mucosal-associated invariant T (MAIT) cells, an abundant population of innate-like T cells, to produce cytokines such as interferon gamma and interleukin (IL) 17, which contribute to host defense against pathogens (Figure 2) (62). It is thought that stimulation by commensal bacteria contributes to the development and activation of MAIT cells for immunological surveillance against pathogens. MAIT cells also produce inflammatory cytokines and have tissue-homing properties, suggesting that these cells are also involved in the development of autoimmune and inflammatory diseases (63).
Figure 2. Regulation of MAIT cells by microbial metabolites derived from vitamin B2 and B9. Commensal bacteria/pathogens produce the vitamin B2 metabolite 6-hydroxymethyl-8-D-ribityllumazine. It binds to major histocompatibility complex (MHC) related protein (MR1) on antigen-presenting cells, which activate mucosal associated invariant T (MAIT) cells to promote the production of inflammatory cytokines such as IFN-γ and IL-17. These reactions contribute to defense against pathogens and conversely are associated with inflammation. In contrast, the vitamin B9 metabolite acetyl-6-formylpterin binds as an antagonist to MR1, thus inhibiting the activation of MAIT cells.
Vitamin B3
Vitamin B3 (niacin) is generally known as nicotinic acid and nicotinamide. These compounds are precursors of nicotinamide adenine dinucleotide (NAD), a coenzyme in the cellular redox reaction with a central role in aerobic respiration. WHO/FAO recommends a daily vitamin B3 intake of 11–12 mg for adults (16).
Vitamin B3 is also a ligand of GPR109a, a G-protein coupled receptor expressed on several types of cells, including immune cells (64). Vitamin B3–GPR109a signaling induces differentiation of regulatory T cells and suppresses colitis in a GPR109a-dependent manner (65). Vitamin B3 also inhibits the production of the pro-inflammatory cytokines IL-1, IL-6, and tumor necrosis factor alpha (TNF-α) by macrophages and monocytes (Figure 3) (66). Thus, vitamin B3 has anti-inflammatory properties by modulating host immune cells and playing an important role in the maintenance of immunological homeostasis. Indeed, in humans, vitamin B3 deficiency causes pellagra, which is a disease characterized by intestinal inflammation, diarrhea, dermatitis, and dementia (67).
Figure 3. Pivotal roles of vitamins B3, B7, and B9 in maintenance of immunological homeostasis. Vitamin B3 binds to GPR109a in dendritic cells and macrophages, and GPR109a signaling leads to an increase in anti-inflammatory properties, resulting in differentiation into regulatory T cells (Treg). Vitamin B7 binds to histones and, by histone biotinylation, suppresses the secretion of pro-inflammatory cytokines. Once naïve T cells differentiate into Treg cells, they highly express folate receptor 4 (FR4). Consistent with this finding, vitamin B9 is required for the survival of Treg cells.
Unlike the other B vitamins, vitamin B3 can be generated by mammals via an endogenous enzymatic pathway from tryptophan and is stored in the liver, although it is also obtained from the diet (68). Animal-based foods such as fish and meat contain vitamin B3 as nicotinamide, and plant-based foods such as beans contain vitamin B3 as nicotinic acid. Both nicotinamide and nicotinic acid are directly absorbed through the small intestine, where nicotinic acid is converted to nicotinamide.
Vitamin B3 is also synthesized from tryptophan by intestinal bacteria (69, 70). Bacteroides fragilis and Prevotella copri (Bacteroidetes); Ruminococcus lactaris, Clostridium difficile (Firmicutes); Bifidobacterium infantis (Actinobacteria); Helicobacter pylori (Proteobacteria); and Fusobacterium varium (Fusobacteria) possess a vitamin B3 biosynthesis pathway (Table 1) (10, 71). Thus, many intestinal bacteria from various genera can produce vitamin B3, suggesting that both dietary and commensal bacteria-derived vitamin B3 are important for host immunity.
Vitamin B5
Vitamin B5 (pantothenic acid) is a precursor of coenzyme A (CoA), which is an essential cofactor for the TCA cycle and fatty acid oxidation (72). WHO/FAO recommends a daily vitamin B5 intake of 5.0 mg for adults (16). Like vitamins B1 and B2, vitamin B5 is involved in the control of host immunity via energy generation by immune cells. Vitamin B5 deficiency causes immune diseases such as dermatitis, as well as non-immune-related conditions such as fatigue and insomnia (73). In a randomized, double-blind, placebo-controlled study in adults, dietary supplementation with vitamin B5 was shown to improve facial acne (74), suggesting that epithelial barrier function improves via the promotion of keratinocyte proliferation and differentiation into fibroblasts (75). To maintain vitamin B5 levels during times of deficiency, CoA is converted back to vitamin B5 or cysteamine via pantetheine (76). However, cysteamine inhibits peroxisome proliferator-activated receptor gamma (PPARγ) signaling, causing inflammation (77). Indeed, colitis has been improved in pantetheine-producing-enzyme knockout mice (78). Thus, vitamin B5 deficiency causes inflammation through both dysfunction of the epithelial barrier and the production of pro-inflammatory molecules.
In terms of immune responses, vitamin B5 enhances protective activity against Mycobacterium tuberculosis infection by promoting innate immunity and adaptive immunity. In mice, vitamin B5 supplementation activates phagocytosis and cytokine production (including IL-6 and TNF-α) by macrophages and subsequently promotes Th1 and Th17 responses for the clearance of M. tuberculosis from the lungs (79). Thus, vitamin B5 contributes to host defense by activating immune responses, suggesting that this vitamin has an important role as a natural adjuvant.
Vitamin B5 is found in high concentrations as CoA or phosphopantetheine in liver, eggs, chicken, and fermented soybeans. CoA and phosphopantetheine are converted to free pantothenic acid by endogenous enzymes such as phosphatase and pantetheinase in the small intestine. Free pantothenic acid is absorbed via sodium-dependent multivitamin transporter (SMVT) expressed on the epithelium of the small intestine and is then released into the blood (80). Finally, free pantothenic acid is converted back to CoA and distributed throughout the body, particularly to the liver and kidney.
Bacterial vitamin B5 is synthesized from 2-dihydropantoate and β-alanine via de novo synthesis pathways (10). Bacterial vitamin B5 exists as free pantothenic acid, which is directly absorbed in the large intestine, converted to CoA, and distributed in the same way as dietary vitamin B5. According to a genomic analysis, Bacteroides fragilis and Prevotella copri (Bacteroidetes); some Ruminococcus spp. (R. lactaris and R. torques) (Firmicutes); Salmonella enterica and Helicobacter pylori (Proteobacteria) possess a vitamin B5 biosynthesis pathway, indicating that intestinal commensal bacteria can produce vitamin B5. In contrast, most Fusobacterium (Fusobacteria) and Bifidobacterium spp. (Actinobacteria) and some strains of Clostridium difficile, Faecalibacterium spp., and Lactobacillus spp. (Firmicutes) lack such a pathway (Table 1), although some of them do express pantothenic acid transporter to utilize vitamin B5 for energy generation (10), suggesting that these bacteria compete with the host for vitamin B5.
Vitamin B6
Vitamin B6 exists in several forms, including as pyridoxine, pyridoxal, and pyridoxamine. These forms of vitamin B6 are precursors of the coenzymes pyridoxal phosphate (PLP) and pyridoxamine phosphate (PMP), which are involved in a variety of cellular metabolic processes, including amino acid, lipid, and carbohydrate metabolism (81). WHO/FAO recommends a daily vitamin B6 intake of 1.3–1.7 mg for adults (16). Vitamin B6 deficiency is associated with the development of inflammatory diseases such as allergy and rheumatoid arthritis, as well as with neuronal dysfunction (82–84). Vitamin B6 deficiency disrupts the Th1–Th2 balance toward an excessive Th2 response, resulting in allergy (85). Moreover, low plasma vitamin B6 levels, together with increased levels of pro-inflammatory cytokines such as TNF-α and IL-6, have been observed in patients with rheumatoid arthritis (86). However, the mechanism underlying the regulation of inflammation by vitamin B6 is currently unknown. Vitamin B6 contributes to intestinal immune regulation through the metabolism of the lipid mediator sphingosine 1-phosphate (S1P). S1P regulates lymphocyte trafficking into the intestines, especially in the large intestine. Lymphocyte trafficking is dependent on S1P gradient which is created by S1P production and its degradation. S1P degradation is mediated by S1P lyase that requires vitamin B6 as a cofactor. The administration of vitamin B6 antagonist impairs S1P lyase activity and creates an inappropriate S1P gradient, resulted in impairing lymphocyte migration from lymphoid tissues and reducing the numbers of lymphocytes in the intestines (87). The lymphocytes located between gut epithelial cells are known as intraepithelial cells (IELs) which are involved in the protection against pathogens (88). Therefore, vitamin B6 is important role for immunosurveillance in the intestines.
Vitamin B6 is abundant in fish, chicken, tofu, sweet potato, and avocado. Dietary vitamin B6 exists as PLP or PMP; it is converted to free vitamin B6 by endogenous enzymes such as pyridoxal phosphatase and is then absorbed by the small intestine. Although absorption of vitamin B6 through acidic pH-dependent and carrier-mediated transport has been shown, an intestinal pyridoxine transporter is yet to be identified in any mammalian species (11). After the absorption of free vitamin B6, it enters the blood and is converted back to PLP or PMP.
Microbial vitamin B6 is synthesized as PLP from deoxyxylulose 5-phosphate and 4-phosphohydroxy-L-threonine or from glyceraldehyde-3-phosphate and d-ribulose 5-phosphate (10). In the large intestine, bacteria-derived PLP is converted to free vitamin B6, which is absorbed by passive transport, transported to the blood, and distributed throughout the body.
Metagenomic analysis has shown that Bacteroides fragilis and Prevotella copri (Bacteroidetes), Bifidobacterium longum and, Collinsella aerofaciens (Actinobacteria), and Helicobacter pylori (Proteobacteria) possess a vitamin B6 biosynthesis pathway. Bacteroidetes and Proteobacteria likely produce vitamin B6 starting from deoxyxylulose 5-phosphate and 4-phosphohydroxy-l-threonine, whereas Actinobacteria likely start from glyceraldehyde-3-phosphate and d-ribulose 5-phosphate. In contrast, most Firmicutes genera (Veillonella, Ruminococcus, Faecalibacterium, and Lactobacillus spp.), except for some Clostridium (C. bartlettii, C. leptum, C. methylpentosum, and C. sporogenes) and Lactobacillus spp. (L. brevis and L. ruminis) lack a vitamin B6 biosynthesis pathway (10) (Table 1).
Vitamin B7
Vitamin B7 (biotin) is a cofactor for several carboxylases that are essential for glucose, amino acid, and fatty acid metabolism (89). For example, vitamin B7 is an essential cofactor for acetyl-CoA carboxylase and fatty acid synthase, which are enzymes involved in fatty acid biosynthesis (90, 91). Thus, vitamin B7 likely influences immunometabolism. WHO/FAO recommends a daily vitamin B7 intake of 30 μg for adults (16). Vitamin B7 suppresses gene expression by binding to (biotinylating) histones; these genes include that encoding NF-κB, which is a major signaling molecule for the production of several pro-inflammatory cytokines (e.g., tumor necrosis factor alpha, IL-1, IL-6, IL-8) (92, 93). Nuclear transcription of NF-κB is activated in response to vitamin B7 deficiency (94), suggesting that biotinylation of histones suppresses the expression of genes encoding pro-inflammatory cytokines in NF-κB signaling (Figure 3). Therefore, vitamin B7 has anti-inflammatory effects by inhibiting NF-κB activation, and dietary vitamin B7 deficiency causes inflammatory responses via enhanced secretion of pro-inflammatory cytokines (95, 96).
Vitamin B7 is abundant in foods such as nuts, beans, and oilseed. However, raw egg-white contains a large amount of avidin, which binds strongly to vitamin B7 and prevents its absorption in the gut (97). Therefore, vitamin B7 deficiency can be caused not only by insufficient vitamin B7 intake, but also by excessive intake of raw egg-white. Dietary biotin exists as a free protein-bound form or as biocytin (11). In the small intestine, biotinidase releases free biotin from the bound protein and the free biotin is absorbed via the biotin transporter SMVT (98).
Vitamin B7 is also produced by intestinal bacteria as free biotin synthesized from malonyl CoA or pimelate via pimeloyl-CoA (99, 100). Bacterial free biotin is absorbed by SMVT expressed in the colon (23, 101). Metagenomic analysis has shown that Bacteroides fragilis and Prevotella copri (Bacteroidetes); Fusobacterium varium (Fusobacteria) and Campylobacter coli (Proteobacteria) possess a vitamin B7 biosynthesis pathway (10). In contrast, Prevotella spp. (Bacteroidetes), Bifidobacterium spp. (Actinobacteria), and Clostridium, Ruminococcus, Faecalibacterium, and Lactobacillus spp. (Firmicutes) lack such a pathway (Table 1); however, they do express free biotin transporter (10, 102), suggesting that these bacteria also utilize dietary and bacterial vitamin B7 and therefore may compete with the host. Thus, free biotin may influence the composition of the gut microbiota, because biotin is necessary for the growth and survival of the microbiota. Indeed, biotin deficiency leads to gut dysbiosis and the overgrowth of Lactobacillus murinus, leading to the development of alopecia (103). Furthermore, vitamin B7 production appears to proceed in a cooperative manner among different intestinal bacteria; Bifidobacterium longum in the intestine produces pimelate, which is a precursor of vitamin B7 that enhances vitamin B7 production by other intestinal bacteria (104).
Vitamin B9
Vitamin B9 (folate), in its active form as tetrahydrofolate, is a cofactor in several metabolic reactions, including DNA and amino acid synthesis. WHO/FAO recommends a daily vitamin B9 intake of 400 μg for adults (16). Owing to the high requirement of vitamin B9 by red blood cells, vitamin B9 deficiency leads to megaloblastic anemia (23). Vitamin B9 deficiency also inhibits the proliferation of human CD8+ T cells in vitro by arresting the cell cycle in the S phase and increasing the frequency of DNA damage (105). Moreover, vitamin B9 contributes to the maintenance of immunologic homeostasis. Regulatory T cells (Treg) express high levels of vitamin B9 receptor (folate receptor 4 [FR4]). Administration of anti-FR4 antibody results in specific reduction in the Treg cell population (106), suggesting that the vitamin B9–FR4 axis is required for Treg cell maintenance. In vitro culture of Treg cells under vitamin B9-reduced conditions leads to impaired cell survival, with decreased expression of anti-apoptotic Bcl2 molecules, although naïve T cells retain the ability to differentiate into Treg cells; this suggests that vitamin B9 is a survival factor for Treg cells (87). Consistent with these findings, deficiency of dietary vitamin B9 results in reduction of the Treg cell population in the small intestine (107, 108). Since Treg cells play an important role in the prevention of excessive immune responses (109), mice fed a vitamin B9-deficient diet exhibit increased susceptibility to intestinal inflammation (107).
Foods such as beef liver, green leafy vegetables, and asparagus contain high levels of vitamin B9. Vitamin B9 exists as both mono- and polyglutamate folate species in the diet (110). Folate polyglutamate is deconjugated to the monoglutamate form and then absorbed in the small intestine via folate transporters such as proton-coupled folate transporter (PCFT) (11, 111). In the intestinal epithelium, folate monoglutamate is converted to tetrahydrofolate (THF), an active form and cofactor, before being transported to the blood (111).
Intestinal bacteria synthesize vitamin B9 as THF from GTP, erythrose 4-phosphate, and phosphoenolpyruvate (38, 112). Bacterial THF is directly absorbed in the colon via PCFT and distributed through the body by the blood (113). Metagenomic analysis has shown that Bacteroides fragilis and Prevotella copri (Bacteroidetes); Clostridium difficile, Lactobacillus plantarum, L. reuteri, L. delbrueckii ssp. bulgaricus, and Streptococcus thermophilus (Firmicutes), some species in Bifidobacterium spp (Actinobacteria); Fusobacterium varium (Fusobacteria) and Salmonella enterica (Proteobacteria) possess a folate biosynthesis pathway (Table 1) (10, 40). This suggests that almost all species in all phyla produce folate. Indeed, dietary supplementation with Bifidobacterium probiotic strains (B. adolescentis and B. pseudocatenulatum) enhances folate production in the large intestine of folate-deficient rats and folate-free culture medium (38, 41, 114). Furthermore, Lactobacillus plantarum, L. delbrueckii ssp. bulgaricus, and L. reuteri enhance folate production in bacterial culture supernatant lacking the components needed for folate synthesis (38, 39, 115).
In commensal bacteria, a vitamin B9 metabolite, 6-formylpterin (6-FP), is produced by photodegradation of folic acid (116). Like the vitamin B2 metabolite 6-hydroxymethyl-8-d-ribityllumazine, 6-FP binds to MR1, but unlike 6-hydroxymethyl-8-d-ribityllumazine it cannot activate MAIT cells (62, 117). An analog of 6-FP, acetyl-6-FP, is an antagonist of MR1, which inhibits MAIT cell activation (118). As mentioned in the section on vitamin B2, 6-hydroxymethyl-8-d-ribityllumazine activates MAIT cells, which provide defense against pathogens, so vitamin B9 metabolites may suppress excess MAIT cell responses and prevent excessive allergic and inflammatory responses (Figure 2). The quantitative balance between dietary vitamin B2 and B9 and the composition of the microbiota and its ability to metabolize these vitamins may be keys to understanding MAIT-cell-mediated homeostasis in the intestine.
Vitamin B12
Vitamin B12 (cobalamin) is a cobalt-containing vitamin that, in its active forms of methylcobalamin and adenosylcobalamin, catalyzes methionine synthesis (119). WHO/FAO recommends a daily vitamin B12 intake of 2.4 μg for adults (16). Together with vitamin B6 and B9, vitamin B12 plays important roles in red blood cell formation and nucleic acid synthesis, especially in neurons. Therefore, vitamin B12 deficiency causes megaloblastic anemia and nervous system symptoms such as numbness of the hands and feet (119). In terms of host immunity, dietary vitamin B12 deficiency decreases the number of CD8+ T cells and suppresses natural killer T-cell activity in mice; supplementation with methylcobalamin improves these conditions (120), suggesting that vitamin B12 contributes to the immune response via CD8+ T cells and natural killer T cells.
Beef liver, bivalves, fish, chicken, and eggs contain high levels of vitamin B12. Dietary vitamin B12 exists in complex with dietary protein and is decomposed to free vitamin B12 by pepsin in the stomach. Free vitamin B12 is absorbed by the epithelial cells of the small intestine via intrinsic factor (IF), a gastric glycoprotein. Inside the epithelial cells, IF-vitamin B12 complex is decomposed to free vitamin B12 by lysosome and then released into the blood, where it is converted to the active form and distributed throughout the body (121, 122).
Bacterial vitamin B12 is synthesized from precorrin-2 to produce adenosylcobalamin (10), which is absorbed directly by the large intestine and distributed throughout the body; the mechanism underlying this absorption is currently unclear. Metagenomic analysis has predicted that Bacteroides fragilis and Prevotella copri (Bacteroidetes); Clostridium difficile, Faecalibacterium prausnitzii and Ruminococcus lactaris (Firmicutes); Bifidobacterium animalis, B.infantis, and B.longum (Actinobacteria); Fusobacterium varium (Fusobacteria) possess a vitamin B12 biosynthesis pathway (Table 1) (10, 32, 42, 43, 45). Indeed, Lactobacillus plantarum and L. coryniformis isolated from fermented food produce vitamin B12 (33), and Bifidobacterium animalis synthesizes vitamin B12 during milk fermentation (123).
Conclusion
B-vitamin-mediated immunological regulation is specific to different immune cells and immune responses: that is, different B vitamins are required for different immune responses (Figure 4). It was once thought that B vitamins were obtained only from the diet; however, we know now that this is not the case and that the intestinal microbiota is also an important source of vitamins. Within the intestinal microbiota, not all bacteria produce B vitamins and some bacteria utilize dietary B vitamins or B vitamins produced by other intestinal bacteria for their own needs; therefore, there may be competition between the host and the intestinal microbiota for B vitamins (Figure 4). Research in this field is complicated, because not only does the composition of the intestinal microbiota vary among individuals, but also the composition of the diet can alter both the composition and function of the intestinal microbiota. Therefore, vitamin-mediated immunological maintenance also varies among individuals. Further examinations in this field are needed, and the new information uncovered will help to develop a new era of precision health and nutrition.
Figure 4. Schematic representation of B-vitamin-mediated interaction between commensal bacteria and host immunity.
Author Contributions
KY and KH wrote the draft of review article which was corrected by JK. KY, KH, and KS drew figures and JK performed correction.
Conflict of Interest Statement
KS was employed by Nippon Flour Mills Co., Ltd.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
This review article contains results obtained from our studies that were supported at least in part by grants from the Japan Agency for Medical Research and Development [AMED; 17fk0108223h0002 (JK), 17ek0410032s0102 (JK), 17fk0108207h0002 (JK), 17ek0210078h0002 (JK), 17ak0101068h0001 (JK), 17gm1010006s0101 (JK), and 19ek0410062h0001 (JK)]; Cross-ministerial Strategic Innovation Promotion Program; the Ministry of Health, Labor, and Welfare of Japan; the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Japan Society for the Promotion of Science [JSPS, JP16H01373 (JK), JP15H05790 (JK), JP17H04134 (JK), JP26670241 (JK), JP26293111 (JK), JP18K17997 (KH), and JP18J00556 (KH)]; the ONO Medical Research Foundation (JK); the Canon Foundation (JK); the Terumo Foundation for the Life Sciences and Arts; and the Nippon Ham Foundation for the Future of Food. KH is a JSPS Research Fellow.
References
1. Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. (2017) 46:562–76. doi: 10.1016/j.immuni.2017.04.008
2. Hirata S-I, Kunisawa J. Gut microbiome, metabolome, and allergic diseases. Allergol Int Off J Jpn Soc Allergol. (2017) 66:523–8. doi: 10.1016/j.alit.2017.06.008
3. Shibata N, Kunisawa J, Kiyono H. Dietary and microbial metabolites in the regulation of host immunity. Front Microbiol. (2017) 8:2171. doi: 10.3389/fmicb.2017.02171
4. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome, and immune system: envisioning the future. Nature. (2011) 474:327–36. doi: 10.1038/nature10213
5. Lamichhane A, Kiyono H, Kunisawa J. Nutritional components regulate the gut immune system and its association with intestinal immune disease development. J Gastroenterol Hepatol. (2013) 28(Suppl. 4):18–24. doi: 10.1111/jgh.12259
6. Whatham A, Bartlett H, Eperjesi F, Blumenthal C, Allen J, Suttle C, et al. Vitamin and mineral deficiencies in the developed world and their effect on the eye and vision. Ophthalmic Physiol Opt. (2008) 28:1–12. doi: 10.1111/j.1475-1313.2007.00531.x
7. Lee W-J, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol. (2014) 10:416–24. doi: 10.1038/nchembio.1535
8. Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. (2016) 16:341–52. doi: 10.1038/nri.2016.42
9. Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. (2017) 4:14. doi: 10.1186/s40779-017-0122-9
10. Magnúsdóttir S, Ravcheev D, de Crécy-Lagard V, Thiele I. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet. (2015) 6:148. doi: 10.3389/fgene.2015.00148
11. Said HM. Intestinal absorption of water-soluble vitamins in health and disease. Biochem J. (2011) 437:357–72. doi: 10.1042/BJ20110326
12. Hosomi K, Kunisawa J. The specific roles of vitamins in the regulation of immunosurveillance and maintenance of immunologic homeostasis in the gut. Immune Netw. (2017) 17:13–9. doi: 10.4110/in.2017.17.1.13
13. Suzuki H, Kunisawa J. Vitamin-mediated immune regulation in the development of inflammatory diseases. Endocr Metab Immune Disord Drug Targets. (2015) 15:212–5. doi: 10.2174/1871530315666150316122128
14. Frank RAW, Leeper FJ, Luisi BF. Structure, mechanism and catalytic duality of thiamine-dependent enzymes. Cell Mol Life Sci. (2007) 64:892–905. doi: 10.1007/s00018-007-6423-5
15. Huskisson E, Maggini S, Ruf M. The role of vitamins and minerals in energy metabolism and well-being. J Int Med Res. (2007) 35:277–89. doi: 10.1177/147323000703500301
16. WHO/FAO. Vitamin and Mineral Requirements in Human Nutrition. 2nd ed. Report of a joint WHO/FAO Expert Consultation, Bangkok, Thailand 1998. Geneva: World Health Organization/Rome: Food and Agriculture Organization of the United Nations (2004).
17. Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev Immunol. (2011) 11:81–3. doi: 10.1038/nri2922
18. Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic Instruction of Immunity. Cell. (2017) 169:570–86. doi: 10.1016/j.cell.2017.04.004
19. Pearce EL, Poffenberger MC, Chang C-H, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. (2013) 342:1242454. doi: 10.1126/science.1242454
20. Shikina T, Hiroi T, Iwatani K, Jang MH, Fukuyama S, Tamura M, et al. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J Immunol. (2004) 172:6259–64. doi: 10.4049/jimmunol.172.10.6259
21. Kunisawa J, Sugiura Y, Wake T, Nagatake T, Suzuki H, Nagasawa R, et al. Mode of bioenergetic metabolism during B cell differentiation in the intestine determines the distinct requirement for vitamin B1. Cell Rep. (2015) 13:122–31. doi: 10.1016/j.celrep.2015.08.063
22. Rindi G, Laforenza U. Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med Soc Exp Biol Med. (2000) 224:246–55. doi: 10.1046/j.1525-1373.2000.22428.x
23. Said HM. Recent advances in transport of water-soluble vitamins in organs of the digestive system: a focus on the colon and the pancreas. Am J Physiol Gastrointest Liver Physiol. (2013) 305:G601–10. doi: 10.1152/ajpgi.00231.2013
24. Barrow BJ, Ortiz-Reyes R, O'Riordan MA, Pretlow TP. In situ localization of enzymes and mucin in normal rat colon embedded in plastic. Histochem J. (1989) 21:289–95. doi: 10.1007/BF01757182
25. Nabokina SM, Inoue K, Subramanian VS, Valle JE, Yuasa H, Said HM. Molecular identification and functional characterization of the human colonic thiamine pyrophosphate transporter. J Biol Chem. (2014) 289:4405–16. doi: 10.1074/jbc.M113.528257
26. Lindhurst MJ, Fiermonte G, Song S, Struys E, De Leonardis F, Schwartzberg PL, et al. Knockout of Slc25a19 causes mitochondrial thiamine pyrophosphate depletion, embryonic lethality, CNS malformations, and anemia. Proc Natl Acad Sci USA. (2006) 103:15927–32. doi: 10.1073/pnas.0607661103
27. Jurgenson CT, Begley TP, Ealick SE. The structural and biochemical foundations of thiamin biosynthesis. Annu Rev Biochem. (2009) 78:569–603. doi: 10.1146/annurev.biochem.78.072407.102340
28. Leonardi R, Roach PL. Thiamine Biosynthesis in Escherichia coli in vitro reconstruction of the thiazole synthase activity. J Biol Chem. (2004) 279:17054–62. doi: 10.1074/jbc.M312714200
29. McRose D, Guo J, Monier A, Sudek S, Wilken S, Yan S, et al. Alternatives to vitamin B1 uptake revealed with discovery of riboswitches in multiple marine eukaryotic lineages. ISME J. (2014) 8:2517–29. doi: 10.1038/ismej.2014.146
30. Taylor SV, Kelleher NL, Kinsland C, Chiu HJ, Costello CA, Backstrom AD, et al. Thiamin biosynthesis in Escherichia coli. Identification of ThiS thiocarboxylate as the immediate sulfur donor in the thiazole formation J Biol Chem. (1998) 273:16555–60. doi: 10.1074/jbc.273.26.16555
31. Drywien M, Frackiewicz J, Górnicka M, Gadek J, Jałosinska M. Effect of probiotic and storage time of thiamine and riboflavin content in the milk drinks fermented by Lactobacillus casei KNE-1. Rocz Panstw Zakl Hig. (2015) 66:373–7.
32. Deguchi Y, Morishita T, Mutai M. Comparative studies on synthesis of water-soluble vitamins among human species of Bifidobacteria. Agric Biol Chem. (1985) 49:13–9.
33. Masuda M, Ide M, Utsumi H, Niiro T, Shimamura Y, Murata M. Production potency of folate, vitamin B12, and thiamine by lactic acid bacteria isolated from Japanese pickles. Biosci Biotechnol Biochem. (2012) 76:2061–7. doi: 10.1271/bbb.120414
34. Levit R, Savoy de Giori G, de Moreno de LeBlanc A, LeBlanc JG. Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis. Benef Microbes. (2016) 8:65–72. doi: 10.3920/BM2016.0063
35. Juarez Del Valle M, Lai-o JE, de Moreno de LeBlanc A, Savoy de Giori G, LeBlanc JG. Soyamilk fermented with riboflavin-producing Lactobacillus plantarum CRL 2130 reverts and prevents ariboflavinosis in murine models. Br J Nutr. (2016) 116:1229–35. doi: 10.1017/S0007114516003378
36. Russo P, Capozzi V, Arena MP, Spadaccino G, Due-as MT, López P, et al. Riboflavin-overproducing strains of Lactobacillus fermentum for riboflavin-enriched bread. Appl Microbiol Biotechnol. (2014) 98:3691–700. doi: 10.1007/s00253-013-5484-7
37. Shah N, Patel A. Recent advances in biosynthesis of vitamin and enzyme from food grade bacteria. Intl J Food Ferment Technol. (2014) 4:79–85. doi: 10.5958/2321-7111.2015.00001.3
38. Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients. (2011) 3:118–34. doi: 10.3390/nu3010118
39. Homayouni Rad A, Yari Khosroushahi A, Khalili M, Jafarzadeh S. Folate bio-fortification of yoghurt and fermented milk: a review. Dairy Sci Technol. (2016) 96:427–41. doi: 10.1007/s13594-016-0286-1
40. Crittenden RG, Martinez NR, Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol. (2003) 80:217–22. doi: 10.1016/S0168-1605(02)00170-8
41. D'Aimmo MR, Mattarelli P, Biavati B, Carlsson NG, Andlid T. The potential of bifidobacteria as a source of natural folate. J Appl Microbiol. (2012) 112:975–84. doi: 10.1111/j.1365-2672.2012.05261.x
42. Song H, Yoo Y, Hwang J, Na Y-C, Kim HS. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J Allergy Clin Immunol. (2016) 137:852–60. doi: 10.1016/j.jaci.2015.08.021
43. Piwowarek K, Lipinska E, Hać-Szymanczuk E, Kieliszek M, Scibisz I. Propionibacterium spp.-source of propionic acid, vitamin B12, and other metabolites important for the industry. Appl Microbiol Biotechnol. (2018) 102:515–38. doi: 10.1007/s00253-017-8616-7
44. Gu Q, Zhang C, Song D, Li P, Zhu X. Enhancing vitamin B12 content in soy-yogurt by Lactobacillus reuteri. Int J Food Microbiol. (2015) 206:56–9. doi: 10.1016/j.ijfoodmicro.2015.04.033
45. Lee J-H, O'Sullivan DJ. Genomic insights into bifidobacteria. Microbiol Mol Biol Rev MMBR. (2010) 74:378–416. doi: 10.1128/MMBR.00004-10
46. Costliow ZA, Degnan PH. Thiamine acquisition strategies impact metabolism and competition in the gut microbe Bacteroides thetaiotaomicron. mSystems. (2017) 2:17. doi: 10.1128/mSystems.00116-17
47. Almeida L, Lochner M, Berod L, Sparwasser T. Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol. (2016) 28:514–24. doi: 10.1016/j.smim.2016.10.009
48. Schramm M, Wiegmann K, Schramm S, Gluschko A, Herb M, Utermöhlen O, et al. Riboflavin (vitamin B2) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes. Eur J Immunol. (2014) 44:728–41. doi: 10.1002/eji.201343940
50. Sundaram U. Regulation of intestinal vitamin B2 absorption. Focus on “Riboflavin uptake by human-derived colonic epithelial NCM460 cells.” Am J Physiol Cell Physiol. (2000) 278:C268–9. doi: 10.1152/ajpcell.2000.278.2.C268
51. Jaeger B, Bosch AM. Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience. J Inherit Metab Dis. (2016) 39:559–64. doi: 10.1007/s10545-016-9924-2
52. Subramanian VS, Lambrecht N, Lytle C, Said HM. Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption. Am J Physiol - Gastrointest Liver Physiol. (2016) 310:G285–93. doi: 10.1152/ajpgi.00340.2015
53. Yonezawa A, Masuda S, Katsura T, Inui K. Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am J Physiol Cell Physiol. (2008) 295:C632–641. doi: 10.1152/ajpcell.00019.2008
54. García-Angulo VA. Overlapping riboflavin supply pathways in bacteria. Crit Rev Microbiol. (2017) 43:196–209. doi: 10.1080/1040841X.2016.1192578
55. Tastan C, Karhan E, Zhou W, Fleming E, Voigt AY, Yao X, et al. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation. Mucosal Immunol. (2018) 11:1591–605. doi: 10.1038/s41385-018-0072-x
56. Duurkens RH, Tol MB, Geertsma ER, Permentier HP, Slotboom DJ. Flavin binding to the high affinity riboflavin transporter RibU. J Biol Chem. (2007) 282:10380–6. doi: 10.1074/jbc.M608583200
57. Chen Z, Wang H, D'Souza C, Sun S, Kostenko L, Eckle SBG, et al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. (2017) 10:58–68. doi: 10.1038/mi.2016.39
58. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. (2010) 8:e1000407. doi: 10.1371/journal.pbio.1000407
59. Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol. (2014) 5:450. doi: 10.3389/fimmu.2014.00450
60. Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, Premel V, et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog. (2013) 9:e1003681. doi: 10.1371/journal.ppat.1003681
61. Thakur K, Tomar SK, De S. Lactic acid bacteria as a cell factory for riboflavin production. Microb Biotechnol. (2015) 9:441–51. doi: 10.1111/1751-7915.12335
62. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. (2012) 491:717–23. doi: 10.1038/nature11605
63. Serriari N-E, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol. (2014) 176:266–74. doi: 10.1111/cei.12277
64. Chai JT, Digby JE, Choudhury RP. GPR109A and vascular inflammation. Curr Atheroscler Rep. (2013) 15:9. doi: 10.1007/s11883-013-0325-9
65. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. (2014) 40:128–39. doi: 10.1016/j.immuni.2013.12.007
66. Lipszyc PS, Cremaschi GA, Zubilete MZ, Bertolino MLA, Capani F, Genaro AM, et al. Niacin modulates pro-inflammatory cytokine secretion. A potential mechanism involved in its anti-atherosclerotic effect Open Cardiovasc Med J. (2013) 7:90–8. doi: 10.2174/1874192401307010090
67. Amanullah S, Seeber C. Niacin deficiency resulting in neuropsychiatric symptoms: A case study and review of literature. Clin Neuropsychiatry. (2010) 7:10–14.
68. Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol. (2018) 8:13. doi: 10.3389/fcimb.2018.00013
69. Gazzaniga F, Stebbins R, Chang SZ, McPeek MA, Brenner C. Microbial NAD metabolism: lessons from comparative genomics. Microbiol Mol Biol Rev. (2009) 73:529–41. doi: 10.1128/MMBR.00042-08
70. Kurnasov O, Goral V, Colabroy K, Gerdes S, Anantha S, Osterman A, et al. NAD biosynthesis: identification of the tryptophan to quinolinate pathway in bacteria. Chem Biol. (2003) 10:1195–204. doi: 10.1016/j.chembiol.2003.11.011
71. Rodionov DA, Li X, Rodionova IA, Yang C, Sorci L, Dervyn E, et al. Transcriptional regulation of NAD metabolism in bacteria: genomic reconstruction of NiaR (YrxA) regulon. Nucleic Acids Res. (2008) 36:2032–46. doi: 10.1093/nar/gkn046
72. Kennedy DO. B Vitamins and the brain: mechanisms, dose and efficacy—a review. Nutrients. (2016) 8:68. doi: 10.3390/nu8020068
73. Hodges RE, Ohlson MA, Bean WB. Pantothenic acid deficiency in man1. J Clin Invest. (1958) 37:1642–57. doi: 10.1172/JCI103756
74. Yang M, Moclair B, Hatcher V, Kaminetsky J, Mekas M, Chapas A, et al. A randomized, double-blind, placebo-controlled study of a novel pantothenic Acid-based dietary supplement in subjects with mild to moderate facial acne. Dermatol Ther. (2014) 4:93–101. doi: 10.1007/s13555-014-0052-3
75. Kobayashi D, Kusama M, Onda M, Nakahata N. The effect of pantothenic acid deficiency on keratinocyte proliferation and the synthesis of keratinocyte growth factor and collagen in fibroblasts. J Pharmacol Sci. (2011) 115:230–4. doi: 10.1254/jphs.10224SC
76. Leonardi R, Zhang Y-M, Rock CO, Jackowski S. Coenzyme A: back in action. Prog Lipid Res. (2005) 44:125–53. doi: 10.1016/j.plipres.2005.04.001
77. Zhang B, Lo C, Shen L, Sood R, Jones C, Cusmano-Ozog K, et al. The role of vanin-1 and oxidative stress–related pathways in distinguishing acute and chronic pediatric ITP. Blood. (2011) 117:4569–79. doi: 10.1182/blood-2010-09-304931
78. Berruyer C, Pouyet L, Millet V, Martin FM, LeGoffic A, Canonici A, et al. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J Exp Med. (2006) 203:2817–27. doi: 10.1084/jem.20061640
79. He W, Hu S, Du X, Wen Q, Zhong X-P, Zhou X, et al. Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis. Front Immunol. (2018) 9:365. doi: 10.3389/fimmu.2018.00365
80. Quick M, Shi L. The sodium/multivitamin transporter: a multipotent system with therapeutic implications. Vitam Horm. (2015) 98:63–100. doi: 10.1016/bs.vh.2014.12.003
81. Parra M, Stahl S, Hellmann H. Vitamin B6 and its role in cell metabolism and physiology. Cells. (2018) 7:84. doi: 10.3390/cells7070084
82. Doke S, Inagaki N, Hayakawa T, Tsuge H. Effect of vitamin B6 deficiency on an antibody production in mice. Biosci Biotechnol Biochem. (1997) 61:1331–6. doi: 10.1271/bbb.61.1331
83. Huang S-C, Wei JC-C, Wu DJ, Huang Y-C. Vitamin B (6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis. Eur J Clin Nutr. (2010) 64:1007–13. doi: 10.1038/ejcn.2010.107
84. Jannusch K, Jockwitz C, Bidmon H-J, Moebus S, Amunts K, Caspers S. A complex interplay of vitamin B1 and B6 metabolism with cognition, brain structure, and functional connectivity in older adults. Front Neurosci. (2017) 11:596. doi: 10.3389/fnins.2017.00596
85. Qian B, Shen S, Zhang J, Jing P. Effects of vitamin B6 deficiency on the composition and functional potential of T cell populations. J Immunol Res. (2017) 2017:2197975. doi: 10.1155/2017/2197975
86. Chiang E-PI, Selhub J, Bagley PJ, Dallal G, Roubenoff R. Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther. (2005) 7:R1404–11. doi: 10.1186/ar1839
87. Kunisawa J, Kiyono H. Vitamin-mediated regulation of intestinal immunity. Front Immunol. (2013) 4:189. doi: 10.3389/fimmu.2013.00189
88. Sheridan BS, Lefrançois L. Intraepithelial lymphocytes: To serve and protect. Curr Gastroenterol Rep. (2010) 12:513–21. doi: 10.1007/s11894-010-0148-6
89. Tong L. Structure and function of biotin-dependent carboxylases. Cell Mol Life Sci. (2013) 70:863–91. doi: 10.1007/s00018-012-1096-0
90. Ikeda M, Miyamoto A, Mutoh S, Kitano Y, Tajima M, Shirakura D, et al. Development of biotin prototrophic and hyper-auxotrophic Corynebacterium glutamicum strains toward biotin production. Appl Env Microbiol. (2013) 2013:828. doi: 10.1128/AEM.00828-13
91. Ikeda M, Nagashima T, Nakamura E, Kato R, Ohshita M, Hayashi M, et al. In vivo roles of fatty acid biosynthesis enzymes in biosynthesis of biotin and α-lipoic acid in Corynebacterium glutamicum. Appl Environ Microbiol. (2017) 83:17. doi: 10.1128/AEM.01322-17
92. Kothapalli N, Camporeale G, Kueh A, Chew YC, Oommen AM, Griffin JB, et al. Biological functions of biotinylated histones. J Nutr Biochem. (2005) 16:446–8. doi: 10.1016/j.jnutbio.2005.03.025
93. Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. (2017) 2:17023. doi: 10.1038/sigtrans.2017.23
94. Rodriguez-Melendez R, Zempleni J. Regulation of gene expression by biotin (review). J Nutr Biochem. (2003) 14:680–90. doi: 10.1016/j.jnutbio.2003.07.001
95. Agrawal S, Agrawal A, Said HM. Biotin deficiency enhances the inflammatory response of human dendritic cells. Am J Physiol Cell Physiol. (2016) 311:C386–391. doi: 10.1152/ajpcell.00141.2016
96. Elahi A, Sabui S, Narasappa NN, Agrawal S, Lambrecht NW, Agrawal A, et al. Biotin deficiency induces Th1- and Th17-mediated proinflammatory responses in human CD4+ T lymphocytes via activation of the mTOR signaling pathway. J Immunol Baltim Md. (2018) 200:2563–70. doi: 10.4049/jimmunol.1701200
97. Zempleni J, Hassan YI, Wijeratne SS. Biotin and biotinidase deficiency. Expert Rev Endocrinol Metab. (2008) 3:715–24. doi: 10.1586/17446651.3.6.715
98. Zempleni J, Wijeratne SSK, Hassan YI. Biotin. BioFactors Oxf Engl. (2009) 35:36–46. doi: 10.1002/biof.8
99. Bi H, Zhu L, Jia J, Cronan JE. A Biotin biosynthesis gene restricted to Helicobacter. Sci Rep. (2016) 6:21162. doi: 10.1038/srep21162
100. Entcheva P, Phillips DA, Streit WR. Functional analysis of Sinorhizobium meliloti genes involved in biotin synthesis and transport. Appl Environ Microbiol. (2002) 68:2843–8. doi: 10.1128/AEM.68.6.2843-2848.2002
101. Sabui S, Bohl JA, Kapadia R, Cogburn K, Ghosal A, Lambrecht NW, et al. Role of the sodium-dependent multivitamin transporter (SMVT) in the maintenance of intestinal mucosal integrity. Am J Physiol Gastrointest Liver Physiol. (2016) 311:G561–70. doi: 10.1152/ajpgi.00240.2016
102. Fisher DJ, Fernández RE, Adams NE, Maurelli AT. Uptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT). PLoS ONE. (2012) 7:e46052. doi: 10.1371/journal.pone.0046052
103. Hayashi A, Mikami Y, Miyamoto K, Kamada N, Sato T, Mizuno S, et al. Intestinal dysbiosis and biotin deprivation induce alopecia through overgrowth of Lactobacillus murinus in mice. Cell Rep. (2017) 20:1513–24. doi: 10.1016/j.celrep.2017.07.057
104. Sugahara H, Odamaki T, Fukuda S, Kato T, Xiao J, Abe F, et al. Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. Sci Rep. (2015) 5:13548. doi: 10.1038/srep13548
105. Courtemanche C, Elson-Schwab I, Mashiyama ST, Kerry N, Ames BN. Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. J Immunol Baltim Md. (2004) 173:3186–92. doi: 10.4049/jimmunol.173.5.3186
106. Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, Nomura T, et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity. (2007) 27:145–59. doi: 10.1016/j.immuni.2007.04.017
107. Kinoshita M, Kayama H, Kusu T, Yamaguchi T, Kunisawa J, Kiyono H, et al. Dietary folic acid promotes survival of Foxp3+ regulatory T cells in the colon. J Immunol. (2012) 189:2869–78. doi: 10.4049/jimmunol.1200420
108. Kunisawa J, Hashimoto E, Ishikawa I, Kiyono H. A pivotal role of vitamin B9 in the maintenance of regulatory T cells in vitro and in vivo. PLoS ONE. (2012) 7:e32094. doi: 10.1371/journal.pone.0032094
109. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol. (2009) 21:1105–11. doi: 10.1093/intimm/dxp095
110. Melse-Boonstra A, de Bree A, Verhoef P, Bjørke-Monsen AL, Verschuren WMM. Dietary monoglutamate and polyglutamate folate are associated with plasma folate concentrations in Dutch men and women aged 20-65 years. J Nutr. (2002) 132:1307–12. doi: 10.1093/jn/132.6.1307
111. Zhao R, Diop-Bove N, Visentin M, Goldman ID. Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr. (2011) 31:177–201. doi: 10.1146/annurev-nutr-072610-145133
112. Maguire F, Henriquez F L, Leonard G, Dacks JB, Brown MW, Richards TA. Complex patterns of gene fission in the eukaryotic folate biosynthesis pathway. Genome Biol Evol. (2014) 6:2709–20. doi: 10.1093/gbe/evu213
113. Maynard C, Cummins I, Green J, Weinkove D. A bacterial route for folic acid supplementation. BMC Biol. (2018) 16:3. doi: 10.1186/s12915-018-0534-3
114. Strozzi GP, Mogna L. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol. (2008) 42(Suppl. 3):S179–84. doi: 10.1097/MCG.0b013e31818087d8
115. Santos F, Wegkamp A, de Vos WM, Smid EJ, Hugenholtz J. High-level folate production in fermented foods by the B12 producer Lactobacillus reuteri JCM1112. Appl Environ Microbiol. (2008) 74:3291–4. doi: 10.1128/AEM.02719-07
116. Araújo MM, Marchioni E, Villavicencio ALCH, Zhao M, di Pascoli T, Kuntz F, et al. Mechanism of folic acid radiolysis in aqueous solution. LWT - Food Sci Technol. (2015) 63:599–603. doi: 10.1016/j.lwt.2015.03.038
117. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SBG, Birkinshaw R, Beddoe T, et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun. (2013) 4:2142. doi: 10.1038/ncomms3142
118. Eckle SBG, Birkinshaw RW, Kostenko L, Corbett AJ, McWilliam HEG, Reantragoon R, et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J Exp Med. (2014) 211:1585–600. doi: 10.1084/jem.20140484
119. Bito T, Watanabe F. Biochemistry, function, and deficiency of vitamin B12 in Caenorhabditis elegans. Exp Biol Med. (2016) 241:1663–8. doi: 10.1177/1535370216662713
120. Tamura J, Kubota K, Murakami H, Sawamura M, Matsushima T, Tamura T, et al. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. (1999) 116:28–32. doi: 10.1046/j.1365-2249.1999.00870.x
121. Beedholm-Ebsen R, van de Wetering K, Hardlei T, Nexø E, Borst P, Moestrup SK. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood. (2010) 115:1632–9. doi: 10.1182/blood-2009-07-232587
122. Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. (2017) 129:2603–11. doi: 10.1182/blood-2016-10-569186
Keywords: absorption, gut microbiota, intestinal immunity, nutrition, vitamin
Citation: Yoshii K, Hosomi K, Sawane K and Kunisawa J (2019) Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity. Front. Nutr. 6:48. doi: 10.3389/fnut.2019.00048
Received: 05 December 2018; Accepted: 01 April 2019;
Published: 17 April 2019.
Edited by:
Carlotta De Filippo, Italian National Research Council (CNR), ItalyReviewed by:
Chiara Devirgiliis, Council for Agricultural Research and Economics, ItalyWilliams Turpin, University of Toronto, Canada
Copyright © 2019 Yoshii, Hosomi, Sawane and Kunisawa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jun Kunisawa, kunisawa@nibiohn.go.jp